Predicting comorbidities in psoriasis using TCM constitution and multimodal data: a prospective cohort study protocol - Takeaways - MDSpire

Assessing Comorbidities in Psoriasis Through TCM Constitution and Multimodal Data: A Protocol for a Prospective Cohort Study

  • By

  • Jing Hu

  • Di Long

  • Junchen Chen

  • Meijunzi Luo

  • Rong Zhou

  • Xuanchun Zhang

  • Ziwan Lei

  • Wenyu Deng

  • Yehong Kuang

  • Haizhen Wang

  • July 21, 2026

Share

  • 1

    This study aims to evaluate the predictive value of Traditional Chinese Medicine (TCM) constitution types for comorbidity risk in psoriasis patients.

  • 2

    A multicenter, prospective cohort will enroll 1000 adults with psoriasis to collect data on TCM constitution and multimodal clinical indicators.

  • 3

    The study will monitor comorbidity progression and assess the effectiveness of systemic therapies over a 52-week period.

  • 4

    Ethics approval has been obtained from relevant medical ethics review committees for the study protocol.

  • 5

    Results will be disseminated through peer-reviewed journals, conferences, and public summaries on hospital websites.

Original Source(s)

Predicting comorbidities in psoriasis using TCM constitution and multimodal data: a prospective cohort study protocol

  • by Jing Hu, Di Long, Junchen Chen, Meijunzi Luo, Rong Zhou, Xuanchun Zhang, Ziwan Lei, Wenyu Deng, Yehong Kuang, Haizhen Wang

  • July 21, 2026

Related Content

Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry

Effectiveness, Safety, and Drug Survival of Bimekizumab in Chronic Plaque Psoriasis over 2 Years: Real-World Experience from Northern Italy

Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis